MD Anderson Cancer Center
Houston, TX, United States
Associate professor of radiation oncology at MD Anderson Cancer Center with a joint appointment in translational molecular pathology and investigational cancer therapeutics. Specializing in the treatment of genitourinary disease with an emphasis on kidney cancer, prostate cancer, and oligometastatic disease. Research focus on clinical trials with a strong translational component.
Disclosures:
Strategies and Evidence for SABR in metastatic RCC
Sunday, September 29, 2024
9:51 AM – 10:10 AM ET